w1880lumitvegfahumanimmunoassay3 w1881lumitvegfahumanimmunoassay3 w1882lumitvegfahumanimmunoassay3 w188a-c-lumit-human-vegf-a-standard-3

ELISA Alternative for VEGF-A Detection

  • Cell-based assay with fast add-and-read protocol​
  • Luminescent detection with any plate-reading luminometer​
  • Scalable to 96- or 384- well plates, protocols included
  • Pack sizes show assay number for 96-well plates

Catalog Number:

Choose a product

Size

Catalog Number: W1880

Please Enquire

Catalog Number: W1881

Please Enquire

Catalog Number: W1882

Please Enquire

Catalog Number: W188A-C

Please Enquire


Request a Sample
Not available in all countries

Overview
Protocols
Specifications
Resources
Related Products

リン酸化または総タンパク質の高速定量

Lumit™ Immunoassay Cellular System は、細胞溶解液に含まれる標的分子を直接測定可能な洗浄のいらない生物発光イムノアッセイです。このアッセイは、適切な一次抗体(お客様提供)が利用可能であれば、あらゆるリン酸化タンパク質、総タンパク質あるいは低分子を検出できるように適合させることができます。

ご参考いただくために、注目度の高いターゲットについて市販の一次抗体を用いて Lumit™ イムノアッセイの評価を行いました。以下のアプリケーションノートには、試用した各一次抗体用のプロトコル、サンプルデータ、最適化条件、および注文情報が記載されされています。

How the Lumit® VEGF-A Immunoassay Works

Primary antibodies to VEGF-A were selected for their specific and sensitive detection and labeled with the LgBiT and SmBiT subunits of NanoBiT® Luciferase. In the presence of VEGF-A, the subunits come together to form an active luciferase enzyme. Addition of optimized substrate generates a bright luminescent signal proportional to VEGF-A levels. The assay recognizes human VEGF-A, but not mouse or rat VEGF-A. It is specific for VEGF-A (121, 165 and 183) and does not cross-react with VEGF-B, -C and -D family members.

Schematic showing Lumit® Immunoassay concept.

Avoid Tedious Wash Steps with Simple One-Plate Protocol

Lumit® Immunoassay Workflow

Lumit™ イムノアッセイ vs. ウェスタンブロッティング

Lumit™ イムノアッセイ はウェスタンブロッティングと較べてより簡単で迅速に同等のデータを得ることができます。

 

Graph showing standard curve for Lumit® VEGF-A (Human) Immunoassay.

Specification

Lumit® VEGF-A Immunoassay

Dynamic Range

17.3–7,500pg/ml

Limit of Detection

4.8pg/ml (3 SD above background)

Minimal Detectable Dose (MDD)

3.6pg/ml (2 SD above background)

Assay Time

70 minutes

Sample Type

Cell culture supernatants

SD=Standard Deviation

High-Throughput Screening Applications

Optimizing the Lumit® IL-6 Immunoassay for High-Throughput Drug Screening

In this webinar, we share key considerations for scaling Lumit® Immunoassays from a single 96-well plate to many 364-well plates and offer tips for optimizing Lumit® Immunoassays for HTS applications. You will also hear Galapagos scientist Dr. Nick Verstraeten share how his team used the Lumit® IL-6 Immunoassay in a screening campaign for antiviral drugs.

View On-Demand Webinar

Lumit® Cytokine Assay Automation for High-Throughput Screening

In this poster, see miniaturization and automation data for Lumit® cytokine assays.

View Poster

Reproducible Detection of VEGF-A Released from Human Epithelial Cells

Bar graph showing a dose-dependent increase in VEGF-A released from human A549 epithelial cells.

Human A549 epithelial cells (20,000/well) were cultured in 96-well plates, and medium was refreshed at different timepoints to track VEGF-A accumulation over two days. After incubation, the Lumit® VEGF-A Immunoassay was used to quantitate VEGF-A in the media.

 

Need to measure a different target?

View our growing portfolio of
Lumit® Immunoassays.

For a biotech that understands time is of significant value, the Lumit® Immunoassays are an essential way for us to gather reliable data fast so that we can reach conclusions and make decisions sooner.

Jonathan Chow, Principal Scientist, Corner Therapeutics

Specifications

Catalog Number:

選択製品の構成品内容

Item Part # Size

Lumit® Detection Substrate B

VB405A 1 × 160μl

Lumit® Detection Buffer B

VB406A 1 × 3.2ml

Anti-hVEGF-A mAb-SmBiT, 500X

W189A 1 × 30μl

Anti-hVEGF-A mAb-LgBiT, 500X

W190A 1 × 30μl

Human VEGF-A Standard

W188A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

Lumit® Detection Substrate B

VB405B 1 × 1.25ml

Lumit® Detection Buffer B

VB406B 1 × 25ml

Anti-hVEGF-A mAb-SmBiT, 500X

W189B 1 × 300μl

Anti-hVEGF-A mAb-LgBiT, 500X

W190B 1 × 300μl

Human VEGF-A Standard

W188A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

Lumit® Detection Substrate B

VB405A 5 × 160μl

Lumit® Detection Buffer B

VB406A 5 × 3.2ml

Anti-hVEGF-A mAb-SmBiT, 500X

W189A 5 × 30μl

Anti-hVEGF-A mAb-LgBiT, 500X

W190A 5 × 30μl

Human VEGF-A Standard

W188A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

Human VEGF-A Standard

W188A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA